Accessibility Menu
 
Compass Pathways Plc logo

Compass Pathways Plc

(NASDAQ) CMPS

Current Price$5.62
Market Cap$531.35M
Since IPO (2020)-81%
5 Year-85%
1 Year+93%
1 Month-20%

Compass Pathways Plc Financials at a Glance

Market Cap

$531.35M

Revenue (TTM)

$0.00

Net Income (TTM)

$287.86M

EPS (TTM)

$-3.05

P/E Ratio

-1.81

Dividend

$0.00

Beta (Volatility)

1.42 (Average)

Price

$5.62

Volume

1,552,155.787

Open

$5.61

Previous Close

$5.62

Daily Range

$5.57 - $5.69

52-Week Range

$2.25 - $8.90

CMPS: Motley Fool Moneyball Superscore

50

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Compass Pathways Plc

Industry

Biotechnology

Employees

156

CEO

Kabir Kumar Nath, MBA

Headquarters

London, W1F 0DQ, GB

CMPS Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-564%

Return on Capital

5%

Return on Assets

-1%

Earnings Yield

-55.25%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$531.35M

Shares Outstanding

96.09M

Volume

1.55M

Short Interest

0.00%

Avg. Volume

2.93M

Financials (TTM)

Gross Profit

$216.50K

Operating Income

$179.04M

EBITDA

$179.04M

Operating Cash Flow

$157.24M

Capital Expenditure

$0.00

Free Cash Flow

$157.24M

Cash & ST Invst.

$149.61M

Total Debt

$20.93M

Compass Pathways Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$5.99K

N/A

Gross Margin

0.00%

N/A

Market Cap

$531.35M

N/A

Market Cap/Employee

$3.20M

N/A

Employees

166

N/A

Net Income

$93.88M

-116.6%

EBITDA

$45.95M

-11.7%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$114.57M

-13.8%

Accounts Receivable

$15.39M

-29.5%

Inventory

$0.00

N/A

Long Term Debt

$15.40M

-38.3%

Short Term Debt

$19.63M

+171.2%

Return on Assets

-1.37%

N/A

Return on Invested Capital

4.78%

N/A

Free Cash Flow

$37.79M

+9.5%

Operating Cash Flow

$37.79M

+9.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PRTAProthena Corporation plc
$10.03+3.19%
FDMT4D Molecular Therapeutics, Inc.
$9.87+6.02%
SNDASonida Senior Living, Inc.
$32.10-0.47%
VREXVarex Imaging Corporation
$10.62+0.09%

Trending Stocks

Symbol / CompanyPricePrice Chg
CYCNCyclerion Therapeutics
$6.38+3.12%
INTCIntel
$48.03+0.09%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.23+0.04%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.45-0.01%

Questions About CMPS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.